<DOC>
	<DOCNO>NCT02194127</DOCNO>
	<brief_summary>Study determine efficacy Anthocyan improve impaired twilight night vision test tolerability safety .</brief_summary>
	<brief_title>Efficacy Tolerability Bilberry Extract Volunteers With Impaired Twilight Night Vision</brief_title>
	<detailed_description />
	<criteria>Healthy subject ( volunteer ) agerelated impaired twilight night Age 50 70 , men woman Written inform consent Full visual acuity ( vision ≥ 0.7 ) accord DIN Standard condition Refraction ≤ +/6.0 high main step Agerelated finding ophthalmologic examination ( anterior chamber eye ground ) Normal intraocular pressure ( 1020 mmHg ) Diabetes mellitus Epilepsy Abnormal visual acuity eye ground ( e.g . cloud lens ) Age related vision problem Glaucoma macular degeneration Disease retina Consumption anthocyan preparation past six month Opthalmologic pathology : cataract , visus &lt; 0.7 , retinal pathology , maculopathy , intraocular pressure ( &gt; 21 mmHg ) , know acute chronic eye disease , use hard contact lenses , eye surgery perform within last 12 month Any serious disorder might interfere his/her participation study evaluation efficacy safety test drug : e.g . diabetes mellitus , anamnestic indication diabetic microangiopathy polyneuropathy , renal insufficiency , hepatic metabolic dysfunction , cardiovascular disease ( hypertension &gt; 160/100 mmHg ) , psychiatric disorder , myasthenia gravis , delirious state , albino Any treatment might interfere evaluation test drug , particular drug know influence eye sight adaptation ( e.g . chloroquine , digitalis , ethambutol , chlorpromazine phenothiazine derivative thioridazine , periciazine , perphenazine ) Known hypersensitivity ingredient study drug Drug alcohol abuse Pregnancy , lactation , woman childbearing potential use establish contraceptive Participation another trial within past 30 day</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>